The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Formela Jean Francois since year 2005.
The trader's CIK number is 1030575.
At the time of this reporting, Formela Jean Francois is the Director of Spero Therapeutics, Inc. .
(stock ticker symbol SPRO).
See this page for all insider trading activities at Spero Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-11-06||SPRO||Spero Therapeutics, Inc.||Buy||428,571||14.00||5,999,994|
|2017-07-07||NTLA||Intellia Therapeutics, Inc.||Sale||30,000||16.77||502,979|
|2017-07-10||NTLA||Intellia Therapeutics, Inc.||Sale||40,000||16.17||646,880|
|2017-07-11||NTLA||Intellia Therapeutics, Inc.||Sale||80,000||16.07||1,285,600|
|2017-03-09||NTLA||Intellia Therapeutics, Inc.||Sale||15,628||13.85||216,432|
|2017-03-10||NTLA||Intellia Therapeutics, Inc.||Sale||5,504||14.06||77,408|
|2012-03-02||HZNP||Horizon Pharma Plc||Buy||828,443||3.62||2,999,792|
|2011-08-02||HZNP||Horizon Pharma Plc||Buy||369,814||9.00||3,328,326|
|2005-10-27||NXTM||Nxstage Medical, Inc.||Buy||99,923||10.00||999,230|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Formela Jean Francois (Director of Spero Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.